Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR lets doctors walk in Patients' shoes to fight mental health stigma

NCT ID NCT07375199

Knowledge-focused Sponsor: Centre Hospitalier Henri Laborit Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a short virtual reality experience can reduce stigma toward people with schizophrenia among healthcare workers and students. Participants will watch two VR videos that simulate hallucinations and paranoid thoughts, then researchers measure changes in attitudes and biases. The goal is to see if immersive perspective-taking can foster empathy and reduce discrimination in healthcare settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality simulation of psychotic symptoms
What this could lead to
If it works, this could point toward a new training tool to reduce stigma and improve empathy among healthcare workers.
What could go wrong
This is an early-stage study with only 128 participants, and it measures attitudes rather than clinical outcomes. The effect may be small or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * aged between 18 and 65 * currently employed as a healthcare professional or enrolled as a advanced-grade student in medicine, nursing, or psychology * no history of psychiatric or addictive disorders (except for tobacco dependence) * covered by French social security * able to provide informed written consent after receiving appropriate information. Exclusion Criteria: * current or past psychiatric or addictive disorder (except tobacco dependence) * use of antipsychotic medication; first-degree family history of schizophrenia; cognitive impairment * susceptibility to cybersickness * recent (\<1 year) or acute neurological disorders * history of epilepsy * known otorhinolaryngologic conditions causing vertigo, nausea or vomiting * pregnancy or breastfeeding * legal protection measures * any condition, in the investigator's opinion that would prevent valid questionnaire completion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schizophrenia disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

schizophrenia Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Schizophrenia disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Unité de Recherche Clinique (URC), Centre Hospitalier Henri Laborit

    Poitiers, 86000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.